55513-0021 Aranesp - CanMED: NDC

Product NDC:

55513-0021

Brand Name:

Aranesp

Generic Name:

Darbepoetin alfa

Dosage Form Name:

INJECTION, SOLUTION

Administration Route:

Intravenous

Subcutaneous

Substances:

Name: Darbepoetin alfa

Strength: 40.0

Unit: ug/.4mL

Packages:

Code: 55513-0021-01

Description:

Effective Date: Feb. 18, 2011

Discontinued:

Code: 55513-0021-04

Description: 1 BLISTER PACK in 1 PACKAGE (55513-021-04) / 4 SYRINGE in 1 BLISTER PACK / .4 mL in 1 SYRINGE (55513-021-01)

Effective Date: Aug. 14, 2006

Discontinued:

SEER*Rx Category:

Ancillary Therapy

Major Class:

Erythropoiesis-Stimulating Agent

Minor Class:

Orphan Drug Designation:

Status:

In Use

CanMED and the Oncology Toolbox